Pages that link to "Q46097998"
Jump to navigation
Jump to search
The following pages link to 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer. (Q46097998):
Displaying 49 items.
- Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer. (Q30354652) (← links)
- Nanoparticle-Based Magnetic Resonance Imaging on Tumor-Associated Macrophages and Inflammation (Q33710955) (← links)
- Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century (Q38645927) (← links)
- Conditioning neoadjuvant therapies for improved immunotherapy of cancer (Q45065285) (← links)
- Liposomal 64Cu-PET Imaging of Anti-VEGF Drug Effects on Liposomal Delivery to Colon Cancer Xenografts (Q47118009) (← links)
- Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care. (Q47189682) (← links)
- Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer (Q47549277) (← links)
- Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery. (Q49502555) (← links)
- Transport of drugs from blood vessels to tumour tissue. (Q50082408) (← links)
- Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics (Q50422486) (← links)
- Progress and challenges towards targeted delivery of cancer therapeutics. (Q52590993) (← links)
- Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment. (Q52707854) (← links)
- Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines. (Q55265623) (← links)
- Fully Automated Production and Characterization of 64 Cu and Proof-of-Principle Small-Animal PET Imaging Using 64 Cu-Labelled CA XII Targeting 6A10 Fab. (Q55457281) (← links)
- Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer (Q57110662) (← links)
- Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models (Q57181925) (← links)
- Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer (Q57295430) (← links)
- Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors (Q57805470) (← links)
- Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies (Q58147367) (← links)
- Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study (Q58589117) (← links)
- Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells (Q58771197) (← links)
- Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems (Q61803672) (← links)
- Delivery technologies for cancer immunotherapy (Q63246400) (← links)
- Remote loading of liposomes with a I-radioiodinated compound and their evaluation by PET/CT in a murine tumor model (Q63727215) (← links)
- Cavitation dose painting for focused ultrasound-induced blood-brain barrier disruption (Q64103279) (← links)
- Clinical cancer nanomedicine (Q65556503) (← links)
- Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges (Q89602909) (← links)
- Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment (Q89638584) (← links)
- Prediction of Anti-cancer Nanotherapy Efficacy by Imaging (Q89736571) (← links)
- Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin (Q90216359) (← links)
- Tumor targeting via EPR: Strategies to enhance patient responses (Q90229748) (← links)
- Nanoparticles in the clinic: An update (Q90404021) (← links)
- Polymer-drug conjugate therapeutics: advances, insights and prospects (Q90439921) (← links)
- PET Imaging of Liposomal Glucocorticoids using 89Zr-oxine: Theranostic Applications in Inflammatory Arthritis (Q90746319) (← links)
- Smart cancer nanomedicine (Q91152077) (← links)
- Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy (Q91579180) (← links)
- Trans-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging (Q91840042) (← links)
- How to Make Anticancer Drugs Cross the Blood-Brain Barrier to Treat Brain Metastases (Q92153794) (← links)
- Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy (Q92244146) (← links)
- Overcoming Physiological Barriers to Nanoparticle Delivery-Are We There Yet? (Q92542752) (← links)
- Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine (Q92564117) (← links)
- Imaging-assisted anticancer nanotherapy (Q92644544) (← links)
- Improving nanotherapy delivery and action through image-guided systems pharmacology (Q92644551) (← links)
- Current outlook on radionuclide delivery systems: from design consideration to translation into clinics (Q92754978) (← links)
- Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models (Q92886775) (← links)
- Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy (Q92955340) (← links)
- Towards rational cancer therapeutics: optimizing dosing, delivery, scheduling and combinations (Q96584392) (← links)
- A framework for designing delivery systems (Q99207740) (← links)
- Engineering precision nanoparticles for drug delivery (Q104073756) (← links)